NCT06643429Active, not recruiting
Impact of Environmental Factors and Metabolomics on Colorectal Cancer.
Impact of Environmental Factors and Metabolomics on Colorectal Cancer Development and Prognosis Based on Environmental Factors and Metabolomics.
Source: ClinicalTrials.gov · Last updated 16 Oct 2024
Brief summary (registry, in English)
Colorectal cancer is one of the malignant tumours with high morbidity and mortality worldwide, posing a serious threat to human health. In recent years, the incidence of colorectal cancer has been on the rise with changes in lifestyle and dietary habits. Although some progress has been made in treatments such as surgery, chemotherapy and radiotherapy, however, the early diagnosis, prognosis assessment and personalised treatment of colorectal cancer still face great challenges. Therefore, it is of great academic value and practical significance to deeply explore the influencing factors of colorectal cancer occurrence, development and its prognosis, especially the research on environmental factors and metabolomics.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 700 (estimated)
- First submitted
- 14 Oct 2024
- Start date
- 1 Oct 2024
- Primary completion date
- 1 Oct 2025
- Lead sponsor
- Dong Peng
- Diseases
- Colorectal cancer
- NCT number
- NCT06643429
What you commit to
- Study type: Observational
- Planned participants: 700
- From 1 Oct 2024 to the primary completion date, 1 Oct 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- patients with primary malignant tumours other than gastric cancer;
- patients with serious cardiopulmonary insufficiency and other systemic diseases that affect the choice of treatment plan;
Other
- patients who are not suitable for enrolment as assessed by the investigator.
Who the study is looking for
- Healthy control group:
- age ≥18 years old;
- no history of malignant tumour;
- willing to participate in this study and sign the informed consent form;
- complete basic data.
- Gastric cancer group:
- age ≥18 years old;
- patients diagnosed with gastric cancer by pathological biopsy before operation;
- no chemotherapy, radiotherapy, targeted and immunotherapy before enrolment;
- willing to participate in this study and sign the informed consent; complete clinical data.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The First Affiliated Hospital of Chongqing Medical University Coordinator of this site? Confirm its status | Chongqing | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.